HomeCompareBMXMF vs SPHD

BMXMF vs SPHD: Dividend Comparison 2026

BMXMF yields 1.00% · SPHD yields 4.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMXMF wins by $4.59M in total portfolio value· pulled ahead in Year 3
10 years
BMXMF
BMXMF
● Live price
1.00%
Share price
$102.25
Annual div
$1.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.62M
Annual income
$3,874,899.32
Full BMXMF calculator →
SPHD
SPHD
● Live price
4.30%
Share price
$49.61
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$567.37
Full SPHD calculator →

Portfolio growth — BMXMF vs SPHD

📍 BMXMF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMXMFSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMXMF + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BMXMF pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMXMF
Annual income on $10K today (after 15% tax)
$85.29/yr
After 10yr DRIP, annual income (after tax)
$3,293,664.42/yr
SPHD
Annual income on $10K today (after 15% tax)
$365.92/yr
After 10yr DRIP, annual income (after tax)
$482.26/yr
At 15% tax rate, BMXMF beats the other by $3,293,182.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMXMF + SPHD for your $10,000?

BMXMF: 50%SPHD: 50%
100% SPHD50/50100% BMXMF
Portfolio after 10yr
$2.32M
Annual income
$1,937,733.34/yr
Blended yield
83.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BMXMF right now

BMXMF
Analyst Ratings
4
Buy
1
Hold
Consensus: Buy
Altman Z
6.7
Piotroski
7/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMXMF buys
0
SPHD buys
0
No recent congressional trades found for BMXMF or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMXMFSPHD
Forward yield1.00%4.30%
Annual dividend / share$1.03$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$4.62M$26.5K
Annual income after 10y$3,874,899.32$567.37
Total dividends collected$4.53M$5.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BMXMF vs SPHD ($10,000, DRIP)

YearBMXMF PortfolioBMXMF Income/yrSPHD PortfolioSPHD Income/yrGap
1$10,901$200.68$11,130$430.50$229.00SPHD
2$12,073$408.90$12,357$447.82$284.00SPHD
3← crossover$13,764$846.46$13,687$464.65+$77.00BMXMF
4$16,532$1,803.86$15,126$480.98+$1.4KBMXMF
5$21,738$4,049.60$16,682$496.78+$5.1KBMXMF
6$33,213$9,953.40$18,362$512.03+$14.9KBMXMF
7$63,964$28,425.29$20,174$526.72+$43.8KBMXMF
8$170,764$102,322.42$22,127$540.84+$148.6KBMXMF
9$693,315$510,597.75$24,230$554.39+$669.1KBMXMF
10$4,616,746$3,874,899.32$26,493$567.37+$4.59MBMXMF

BMXMF vs SPHD: Complete Analysis 2026

BMXMFStock

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Full BMXMF Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this BMXMF vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMXMF vs SCHDBMXMF vs JEPIBMXMF vs OBMXMF vs KOBMXMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.